Literature DB >> 34453527

Estimating the Latent Period of Coronavirus Disease 2019 (COVID-19).

Hualei Xin1, Yu Li2, Peng Wu1,3, Zhili Li2, Eric H Y Lau1,3, Ying Qin2, Liping Wang2, Benjamin J Cowling1,3, Tim K Tsang1, Zhongjie Li2.   

Abstract

Using detailed exposure information on COVID-19 cases, we estimated the mean latent period to be 5.5 (95% CI: 5.1-5.9) days, shorter than the mean incubation period (6.9 days). Laboratory testing may allow shorter quarantines since 95% of COVID-19 cases shed virus within 10.6 (95% CI: 9.6-11.6) days of infection.
© The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  COVID-19; SARS-CoV-2; incubation period; latent period

Mesh：

Year:  2022        PMID： 34453527     DOI： 10.1093/cid/ciab746

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  19 in total

1.  Investigating vaccine-induced immunity and its effect in mitigating SARS-CoV-2 epidemics in China.

Authors:  Hengcong Liu; Juanjuan Zhang; Wenhong Zhang; Marco Ajelli; Hongjie Yu; Jun Cai; Xiaowei Deng; Cheng Peng; Xinghui Chen; Juan Yang; Qianhui Wu; Xinhua Chen; Zhiyuan Chen; Wen Zheng; Cécile Viboud
Journal:  BMC Med       Date:  2022-01-31       Impact factor: 8.775

2.  HOW DOES THE LATENCY PERIOD IMPACT THE MODELING OF COVID-19 TRANSMISSION DYNAMICS?

Authors:  Ben Patterson; Jin Wang
Journal:  Math Appl Sci Eng       Date:  2022-02-20

3.  Infection-induced immunity is associated with protection against SARS-CoV-2 infection, but not decreased infectivity during household transmission.

Authors:  Aaron M Frutos; Guillermina Kuan; Roger Lopez; Sergio Ojeda; Abigail Shotwell; Nery Sanchez; Saira Saborio; Miguel Plazaola; Carlos Barilla; Eben Kenah; Angel Balmaseda; Aubree Gordon
Journal:  medRxiv       Date:  2022-10-11

Review 4.  SARS-CoV-2 Transmission and Prevention in the Era of the Delta Variant.

Authors:  Eric A Meyerowitz; Aaron Richterman
Journal:  Infect Dis Clin North Am       Date:  2022-02-01       Impact factor: 5.905

5.  Projecting COVID-19 Mortality as States Relax Nonpharmacologic Interventions.

Authors:  Benjamin P Linas; Jade Xiao; Ozden O Dalgic; Peter P Mueller; Madeline Adee; Alec Aaron; Turgay Ayer; Jagpreet Chhatwal
Journal:  JAMA Health Forum       Date:  2022-04-01

6.  Within-host diversity improves phylogenetic and transmission reconstruction of SARS-CoV-2 outbreaks.

Authors:  Arturo Torres Ortiz; Michelle Kendall; Nathaniel Storey; James Hatcher; Helen Dunn; Sunando Roy; Rachel Williams; Charlotte Williams; Richard A Goldstein; Xavier Didelot; Kathryn Harris; Judith Breuer; Louis Grandjean
Journal:  bioRxiv       Date:  2022-06-07

7.  Are the Current Guidelines Sufficient to Establish Infection Control Strategies for COVID-19 Related Issues in Hospitals?

Authors:  Wooyoung Jang; Bongyoung Kim; Eu Suk Kim; Kyoung-Ho Song; Song Mi Moon; Myung Jin Lee; Ji Young Park; Ji-Yeon Kim; Myoung Jin Shin; Hyunju Lee; Hong Bin Kim
Journal:  J Korean Med Sci       Date:  2021-12-27       Impact factor: 2.153

8.  Reassessing Reported Deaths and Estimated Infection Attack Rate during the First 6 Months of the COVID-19 Epidemic, Delhi, India.

Authors:  Margarita Pons-Salort; Jacob John; Oliver J Watson; Nicholas F Brazeau; Robert Verity; Gagandeep Kang; Nicholas C Grassly
Journal:  Emerg Infect Dis       Date:  2022-02-25       Impact factor: 6.883

9.  Evaluating COVID-19 control measures in mass gathering events with vaccine inequalities.

Authors:  Ali M Al-Shaery; Bilal Hejase; Abdessamad Tridane; Norah S Farooqi; Hamad Al Jassmi
Journal:  Sci Rep       Date:  2022-03-07       Impact factor: 4.379

10.  Transmission dynamics and epidemiological characteristics of SARS-CoV-2 Delta variant infections in Guangdong, China, May to June 2021.

Authors:  Min Kang; Hualei Xin; Jun Yuan; Sheikh Taslim Ali; Zimian Liang; Jiayi Zhang; Ting Hu; Eric Hy Lau; Yingtao Zhang; Meng Zhang; Benjamin J Cowling; Yan Li; Peng Wu
Journal:  Euro Surveill       Date:  2022-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.